Lista de obras - Arild Nesbakken - Dominio Público Uruguay

A novel transcript, VNN1-AB, as a biomarker for colorectal cancer

artículo científico publicado en 2014

A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors

artículo científico publicado en 2012

Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer

artículo científico publicado en 2018

Anticipating the clinical use of prognostic gene expression-based tests for colon cancer stage II and III: is Godot finally arriving?

artículo científico publicado en 2013

B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome

artículo científico publicado en 2014

CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer

article

CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.

artículo científico publicado en 2018

Chromatin organisation and cancer prognosis: a pan-cancer study

artículo científico publicado en 2018

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis ⬇️

artículo científico publicado el 2 de enero de 2012

ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients

artículo científico publicado en 2012

Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies

artículo científico publicado en 2017

Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing

artículo científico publicado en 2013

Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome

artículo científico publicado en 2011

Correction: Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage

scientific article published on 01 October 2019

CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers

artículo científico publicado en 2017

DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset

artículo científico publicado en 2010

Deep learning for prediction of colorectal cancer outcome: a discovery and validation study

scientific article published on 01 February 2020

Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2

artículo científico publicado en 2019

Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci

artículo científico publicado en 2010

Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer

scientific article published on 24 June 2019

Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains

artículo científico publicado en 2019

Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases

artículo científico publicado en 2019

High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases

artículo científico publicado en 2019

High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants

artículo científico publicado en 2014

Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas

artículo científico publicado en 2011

Lymph Node Micrometastases and Isolated Tumor Cells Influence Survival in Stage I and II Colon Cancer ⬇️

artículo científico publicado el 1 de febrero de 2011

MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer

artículo científico publicado en 2012

Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series

artículo científico publicado en 2012

Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1

artículo científico publicado en 2017

National Early Rectal Cancer Treatment Revisited

artículo científico publicado en 2016

Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010.

artículo científico publicado en 2015

Patient-derived organoids from multiple colorectal cancer liver metastases reveal moderate intra-patient pharmacotranscriptomic heterogeneity

scientific article published on 16 April 2020

Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors

artículo científico publicado en 2011

Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome

artículo científico publicado en 2011

Portrait of the PI3K/AKT pathway in colorectal cancer

artículo científico publicado en 2014

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study

artículo científico publicado en 2017

Preoperative staging and treatment options in T1 rectal adenocarcinoma.

artículo científico publicado en 2009

Prognostic Impact of Lymph Node Harvest and Lymph Node Ratio in Patients With Colon Cancer ⬇️

artículo científico publicado el 1 de marzo de 2012

Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series

artículo científico publicado en 2014

Prognostic impact of genomic instability in colorectal cancer

artículo científico publicado en 2014

Prognostic markers for colorectal cancer; estimating ploidy and stroma

artículo científico publicado en 2017

Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy

artículo científico publicado en 2016

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer

scholarly article by Jarle Bruun et al published September 2018 in Molecular Oncology

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer.

artículo científico publicado en 2018

Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer

artículo científico publicado en 2015

Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer

artículo científico publicado en 2019

SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis

artículo científico publicado en 2011

Sentinel node mapping does not improve staging of lymph node metastasis in colonic cancer

artículo científico publicado en 2008

Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study

artículo científico publicado en 2016

Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer

scientific article published on 31 October 2019

The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer.

artículo científico publicado en 2012

The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers

artículo científico publicado en 2014

Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer

Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival

artículo científico publicado en 2011

Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage

scientific article published on 07 August 2019

UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy

artículo científico publicado en 2010

Lista de obras de Arild Nesbakken

A novel transcript, VNN1-AB, as a biomarker for colorectal cancer

A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors

Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer

Anticipating the clinical use of prognostic gene expression-based tests for colon cancer stage II and III: is Godot finally arriving?

B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome

CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer

CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.

Chromatin organisation and cancer prognosis: a pan-cancer study

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis ⬇️

ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients

Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies

Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing

Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome

Correction: Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage

CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers

DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset

Deep learning for prediction of colorectal cancer outcome: a discovery and validation study

Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2

Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci

Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer

Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains

Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases

High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases

High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants

Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas

Lymph Node Micrometastases and Isolated Tumor Cells Influence Survival in Stage I and II Colon Cancer ⬇️

MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer

Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series

Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1

National Early Rectal Cancer Treatment Revisited

Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010.

Patient-derived organoids from multiple colorectal cancer liver metastases reveal moderate intra-patient pharmacotranscriptomic heterogeneity

Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors

Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome

Portrait of the PI3K/AKT pathway in colorectal cancer

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study

Preoperative staging and treatment options in T1 rectal adenocarcinoma.

Prognostic Impact of Lymph Node Harvest and Lymph Node Ratio in Patients With Colon Cancer ⬇️

Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series

Prognostic impact of genomic instability in colorectal cancer

Prognostic markers for colorectal cancer; estimating ploidy and stroma

Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer.

Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer

Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer

SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis

Sentinel node mapping does not improve staging of lymph node metastasis in colonic cancer

Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study

Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer

The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer.

The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers

Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer

Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival

Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage

UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy